Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 2345B | — |
Adult dose administered to a pediatric patient; Adult dose administered to a pediatric patient; Expired vaccine used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of overdose in a 1-year-old female patient who received HAV (Havrix adult) (batch number 2345B, expiry date 02-FEB-2026) for prophylaxis. On 17-FEB-2026, the patient received Havrix adult. On 17-FEB-2026, an unknown time after receiving Havrix adult, the patient experienced overdose (Verbatim: Adult dose administered to a pediatric patient), adult product administered to child (Verbatim: Adult dose administered to a pediatric patient) and expired vaccine used (Verbatim: Expired vaccine used). The outcome of the overdose, adult product administered to child and expired vaccine used were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-FEB-2026 The reporter wanted to know if there was any possible side effect and asked if there were anything that we have to look for. The batch number was provided and a request for this information has been made.